|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Laskin JJ and Sandler AB: State of the art
in therapy for non-small cell lung cancer. Cancer Invest.
23:427–442. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takasaki S: Roles of microRNAs in cancers
and development. Methods Mol Biol. 1218:375–413. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Wang Y, Song Y, Fu Z and Yu W:
miR-27a regulates cisplatin resistance and metastasis by targeting
RKIP in human lung adenocarcinoma cells. Mol Cancer. 13:1932014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wozniak MB, Scelo G, Muller DC, Mukeria A,
Zaridze D and Brennan P: Circulating microRNAs as non-invasive
biomarkers for early detection of non-small-cell lung cancer. PLoS
One. 10:e01250262015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang YX, Chang YL and Gao WQ: MicroRNAs
targeting prostate cancer stem cells. Exp Biol Med. 240:1071–1078.
2015. View Article : Google Scholar
|
|
11
|
Liz J and Esteller M: lncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mao C, Liu H, Chen P, Ye J, Teng L, Jia Z
and Cao J: Cell-specific expression of artificial microRNAs
targeting essential genes exhibit potent antitumor effect on
hepatocellular carcinoma cells. Oncotarget. 6:5707–5719. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao C, Wang G, Zhu Y, Li X, Yan F, Zhang
C, Huang X and Zhang Y: Aberrant regulation of miR-15b in human
malignant tumors and its effects on the hallmarks of cancer. Tumour
Biol. 37:177–183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xi Y, Formentini A, Chien M, Weir DB,
Russo JJ and Ju J, Kornmann M and Ju J: Prognostic values of
microRNAs in colorectal cancer. Biomark Insights. 2:113–121.
2006.PubMed/NCBI
|
|
15
|
Li J, Chen Y, Guo X, Zhou L, Jia Z, Tang
Y, Lin L, Liu W and Ren C: Inhibition of miR-15b decreases cell
migration and metastasis in colorectal cancer. Tumour Biol.
37:8765–8773. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chung GE, Yoon JH, Myung SJ, Lee JH, Lee
SH, Lee SM, Kim SJ, Hwang SY, Lee HS and Kim CY: High expression of
microRNA-15b predicts a low risk of tumor recurrence following
curative resection of hepatocellular carcinoma. Oncol Rep.
23:113–119. 2010.PubMed/NCBI
|
|
17
|
Xia H, Qi Y, Ng SS, Chen X, Chen S, Fang
M, Li D, Zhao Y, Ge R, Li G, et al: MicroRNA-15b regulates cell
cycle progression by targeting cyclins in glioma cells. Biochem
Biophys Res Commun. 380:205–210. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun
S, Hong L, Liu J and Fan D: miR-15b and miR-16 modulate multidrug
resistance by targeting BCL2 in human gastric cancer cells. Int J
Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Huang F, Wang J, Peng L and Luo
H: MiR-15b mediates liver cancer cells proliferation through
targeting BCL-2. Int J Clin Exp Pathol. 8:15677–15683.
2015.PubMed/NCBI
|
|
20
|
Xia Y, Chen Q, Zhong Z, Xu C, Wu C, Liu B
and Chen Y: Down-regulation of miR-30c promotes the invasion of
non-small cell lung cancer by targeting MTA1. Cell Physiol Biochem.
32:476–485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu N, Zhang C, Bai C, Han YP and Li Q:
MiR-4782-3p inhibited non-small cell lung cancer growth via USP14.
Cell Physiol Biochem. 33:457–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Quann K, Jing Y and Rigoutsos I:
Post-transcriptional regulation of BRCA1 through its coding
sequence by the miR-15/107 group of miRNAs. Front Genet. 6:2422015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bode W, Reinemer P, Huber R, Kleine T,
Schnierer S and Tschesche H: The X-ray crystal structure of the
catalytic domain of human neutrophil collagenase inhibited by a
substrate analogue reveals the essentials for catalysis and
specificity. EMBO J. 13:1263–1269. 1994.PubMed/NCBI
|
|
25
|
Johansson E, Komuro A, Iwata C, Hagiwara
A, Fuse Y, Watanabe A, Morishita Y, Aburatani H, Funa K, Kano MR,
et al: Exogenous introduction of tissue inhibitor of
metalloproteinase 2 reduces accelerated growth of TGF-β-disrupted
diffuse-type gastric carcinoma. Cancer Sci. 101:2398–2403. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mendes O, Kim HT, Lungu G and Stoica G:
MMP2 role in breast cancer brain metastasis development and its
regulation by TIMP2 and ERK1/2. Clin Exp Metastasis. 24:341–351.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rigg AS and Lemoine NR: Adenoviral
delivery of TIMP1 or TIMP2 can modify the invasive behavior of
pancreatic cancer and can have a significant antitumor effect in
vivo. Cancer Gene Ther. 8:869–878. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu M, Zhang N, He S, Lui Y, Lu G and Zhao
L: MicroRNA-106a targets TIMP2 to regulate invasion and metastasis
of gastric cancer. FEBS Lett. 588:600–607. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dai Y, Xia W, Song T, Su X, Li J, Li S,
Chen Y, Wang W, Ding H, Liu X, et al: MicroRNA-200b is
overexpressed in endometrial adenocarcinomas and enhances MMP2
activity by downregulating TIMP2 in human endometrial cancer cell
line HEC-1A cells. Nucleic Acid Ther. 23:29–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang F, Wang W, Zhou C, Xi W, Yuan L, Chen
X, Li Y, Yang A, Zhang J and Wang T: MiR-221/222 promote human
glioma cell invasion and angiogenesis by targeting TIMP2. Tumour
Biol. 36:3763–3773. 2015. View Article : Google Scholar : PubMed/NCBI
|
